CD14 rs2569190: What Your Genotype Means
The rs2569190 variant is a common single-nucleotide polymorphism located in the promoter region of the CD14 gene. It is primarily studied for its potential role in modulating the body's immune response to endotoxins and its association with allergic sensitization and inflammatory conditions.
What each genotype means
Baseline CD14 expression
This genotype is often referred to in literature as the -159C or -260C variant. Research suggests that individuals with this genotype may have different responses to environmental endotoxin exposure compared to those with the T allele, potentially influencing the risk of allergic sensitization in specific environments.
This is a common genotype found in approximately 25-30% of individuals of European ancestry.
Intermediate CD14 expression
Carrying one copy of each allele results in an intermediate profile regarding CD14 gene regulation. Studies indicate that the interaction between this genotype and environmental factors, such as early-life exposure to farm environments or endotoxins, may play a role in modulating immune system priming and allergy risk.
This heterozygous genotype is the most common form, appearing in roughly 45-50% of individuals of European ancestry.
Enhanced CD14 expression
This genotype, sometimes noted as -159T or -260T, has been associated in some studies with higher levels of soluble CD14 and increased sensitivity to endotoxin (LPS). While research is mixed and findings have not been uniformly replicated across all populations, this variant may influence how your immune system reacts to certain environmental triggers.
This genotype is present in approximately 20-25% of individuals of European ancestry.
Understanding the rs2569190 Variant
The rs2569190 variant, often referred to in older literature as C-260T or C-159T, is a genetic change located in the promoter region of the CD14 gene on chromosome 5. A promoter region is a segment of DNA that acts as a control switch, determining how much of a specific protein is produced by the cell. Because this variant sits in a regulatory area, researchers have long hypothesized that it influences the expression levels of the CD14 protein. By altering the binding sites for transcription factors, this SNP may change how the gene responds to environmental signals. It is a well-studied marker in the context of innate immunity, serving as a focal point for understanding how subtle genetic differences can lead to variations in how individuals process external biological triggers.
The Role of the CD14 Gene
The CD14 gene provides instructions for creating the CD14 protein, which is a critical component of the innate immune system. This protein acts as a receptor that recognizes lipopolysaccharides (LPS), which are components found on the outer membranes of certain bacteria, often called endotoxins. When CD14 binds to these bacterial components, it works alongside other molecules like TLR4 and MD2 to trigger an inflammatory response. This process is essential for the body to detect and fight off bacterial infections. However, because this system is highly sensitive, variations in CD14 expression can lead to differences in how strongly the immune system reacts to environmental exposures. This makes the gene a primary candidate for research into conditions where immune regulation is key, such as asthma, atopy, and various inflammatory diseases.
Research and Evidence Strength
Research into rs2569190 has produced mixed and sometimes conflicting results, leading to a classification of limited evidence regarding its clinical impact. Some studies suggest that the T allele may lead to higher levels of CD14 expression, potentially increasing sensitivity to endotoxins. This has been linked in some reports to an increased risk of allergic sensitization or more severe inflammatory responses in specific contexts, such as exposure to farm environments or smoking. However, these findings have not been consistently replicated across all populations or study designs. The interaction between this genotype and environmental factors is complex; for instance, some research indicates that the protective effect of early-life endotoxin exposure against atopy may depend on an individual's specific CD14 genotype. Because of these inconsistencies, the variant is not considered a definitive diagnostic tool for any medical condition.
Population Frequency
The rs2569190 variant is common across global populations. In European populations, the minor allele frequency is approximately 0.48, while in East Asian populations, it is approximately 0.45. Because the variant is so prevalent, it is found in a large portion of the general population, meaning that most people carry at least one copy of the minor allele. This high frequency is one reason why researchers have been able to conduct large-scale association studies, but it also highlights that the variant is a normal part of human genetic diversity rather than a rare mutation. Understanding these frequencies is important for researchers to ensure that genetic studies are representative of diverse ancestries, as the impact of a variant can sometimes vary depending on the genetic background of the population being studied.
Interpreting Your Genetic Information
It is important to understand that having a particular genotype for rs2569190 does not mean you will develop any specific disease. Genetic associations are statistical observations made across large groups of people and do not predict individual health outcomes. Many factors, including your environment, lifestyle, and the rest of your genetic makeup, play a much larger role in your immune health than any single SNP. If you have concerns about allergies, asthma, or your immune response, you should consult with a healthcare professional or an allergist. They can provide personalized medical advice based on your clinical history and symptoms. You should never use information from genetic testing to make medical decisions or change your health habits without first discussing it with a qualified clinician.
How common is this variant?
The rs2569190 variant is common, with a minor allele frequency of approximately 0.48 in Europeans and 0.45 in East Asians.
Frequently asked questions
Does the rs2569190 variant cause asthma?
No, this variant does not cause asthma. While some studies have explored a statistical link between this SNP and allergic conditions, the evidence is inconsistent and does not establish a direct cause-and-effect relationship.
Can I use this SNP to predict my allergy risk?
No, you cannot use this SNP to predict your risk of developing allergies. Allergy development is a complex process involving many genes and environmental factors, and this variant is not a reliable diagnostic tool.
What should I do if I have the T/T genotype?
The T/T genotype is a common genetic variation and does not require any specific medical action. If you have concerns about your immune health or allergies, please discuss them with your doctor.
Is this variant related to how I respond to medications?
There is no established evidence that rs2569190 dictates how you respond to specific medications. Always consult your pharmacist or clinician regarding any questions about your prescribed treatments.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2569190?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29